What is Fauna Bio?
Fauna Bio is a pioneering biotechnology company dedicated to exploring the intricate field of animal genomics. Its core mission revolves around understanding how genetic insights derived from animal species can be translated into novel and improved human therapies. By focusing on this interdisciplinary approach, Fauna Bio positions itself at the forefront of genetic research, aiming to unlock new avenues for medical breakthroughs and enhance the efficacy of existing treatments. The company's work in this specialized area of life sciences is critical for advancing personalized medicine and addressing unmet medical needs.
How much funding has Fauna Bio raised?
Fauna Bio has raised a total of $13.1M across 2 funding rounds:
Angel/Seed
$4.1M
Angel/Seed
$9M
Angel/Seed (2019): $4.1M, investors not publicly disclosed
Angel/Seed (2021): $9M led by True Ventures, Boom Capital, and Lifeforce Capital Gp I
Key Investors in Fauna Bio
Lifeforce Capital Gp I
Lifeforce Capital is a venture capital firm that focuses on identifying and scaling software-driven companies in healthcare. The company was established in 2015, indicating a strategic interest in health-tech innovations.
True Ventures
True Ventures is a venture capital firm known for investing in early-stage technology companies. Their participation suggests an interest in Fauna Bio's foundational technology and potential for disruptive innovation.
Boom Capital
Boom Capital is an investment firm. Their involvement in Fauna Bio's funding round indicates a strategic alignment with the company's growth objectives and market potential.
What's next for Fauna Bio?
With the recent infusion of major strategic investment, Fauna Bio is poised for an accelerated phase of development and expansion. This substantial backing is expected to fuel further research and development initiatives, potentially enabling the company to scale its operations and broaden its therapeutic pipeline. The strategic nature of this financing suggests a focus on market penetration and the advancement of its genomic technologies towards clinical application. Fauna Bio's trajectory indicates a strong commitment to translating complex genetic research into tangible health benefits, positioning it for significant impact within the biotechnology sector.
See full Fauna Bio company page
